Diabet. Med. 29, 1510–1514 (2012)
Aims We aimed to assess the relative risk for hypothyroidism in patients with Type 2 diabetes.
Methods In this study, 1112 patients with Type 2 diabetes (58% women, mean age 66.7 years, median duration of diabetes 10 years, 179 with previous history of thyroid disease) and 911 subjects without diabetes were evaluated.
Results The gender-, age- and weight-adjusted relative risk (odds ratio) of newly identified hypothyroidism in patients with Type 2 diabetes in comparison with control subjects was 2.81 (1.77–4.48). This odds ratio was significant in patients over 65 years [4.02 (1.95–8.31)], as well as in both men [4.84 (1.58–14.80)] and women [2.60 (1.54–4.38)], in obese patients [2.56 (1.36–4.82)] and non-obese patients [3.11 (1.56–6.20)] and in individuals with [4.26 (1.73–10.46)] and without [2.93 (1.50–5.75)] thyroid autoantibodies. Logistic regression analysis showed that newly diagnosed hypothyroidism was significantly and directly related not only with thyroid autoimmunity [19.15 (8.73–42.01)], but also with the presence of macroangiopathy [2.85 (1.51–5.35)] and metformin treatment [2.51 (1.28–4.92)].
Conclusions Our results favour screening for hypothyroidism in patients with Type 2 diabetes older than 65 years, especially in the presence of diabetic macroangiopathy or treatment with metformin.